Bio Medica Laboratories IPO Date, Review, Price, Allotment Details

Bio Medica Laboratories IPO is offering its shares to the public for the first time through an IPO on the stock exchanges NSE SME. The total amount they aim to raise is 37,72,000 shares (agg. up to ₹52 Cr). Out of this 35,83,000 shares (agg. up to ₹50 Cr) will be through new shares, and 3,77,000 shares of ₹10 (agg. up to ₹5 Cr) through existing shares. The IPO is open for subscription from 21 May, 2026 to 25 May, 2026. Each share has a face value of Rs 10, and investors can apply for shares at a price between ₹132 to ₹139 per share. The minimum number of shares one can apply for is 1000, or multiples of that as mentioned in the offer document.
  Check Live IPO GMP List  👈
  Check Live IPO  Subscription List  👈
  Check All IPO  Allotment List  👈
Upcoming

Bio Medica Laboratories IPO Details

IPO Category Type: SME
IPO Open: 21 May, 2026
IPO Close: 25 May, 2026
IPO Price Band: ₹132 to ₹139 per share
Face Value: ₹10 Per Equity Share
IPO Listing on: NSE SME
IPO Issue Type: Book Build Issue
IPO Size: Approx 37,72,000 shares (agg. up to ₹52 Cr)
Fresh Issue: Approx 35,83,000 shares (agg. up to ₹50 Cr)
Offer for Sale: Approx 3,77,000 shares of ₹10 (agg. up to ₹5 Cr)

Bio Medica Laboratories IPO Reservation

Retail Quota: 50.01%
QIB Quota: 1.00%
NII Quota: 48.98%
Employee Discount: [.]

Bio Medica Laboratories IPO Prospectus

DRHP Draft Prospectus: [.]
RHP Draft Prospectus: [.]
Anchor Investors List: [.]

Bio Medica Laboratories IPO Market Lot Details

Application Lot Size Shares Amount
1 1000 ₹139000
Application Lot Size Shares Amount
Individual investors (Retail) (Min) 2 2,000 278000
Individual investors (Retail) (Max) 2 2,000 278000
S-HNI (Min) 3 3,000 417000
S-HNI (Max) 7 7,000 973000
B-HNI (Min) 8 8,000 1112000

Bio Medica Laboratories IPO Dates

IPO Activity Date
Open Date: 21 May, 2026
Close Date: 25 May, 2026
Allotment Date: 26 May, 2026
Refund Date: 27 May, 2026
Shares Credit Date: 27 May, 2026
Listing Date: 29 May, 2026

Bio Medica Laboratories Company Financial Report

Period Ended 30 Nov 2025 31 Mar 2025 31 Mar 2024 31 Mar 2023
Assets 65.17 39.12 19.53 17.57
Total Income 28.63 38.33 15.34 16.25
Profit After Tax 8.66 9.79 2.50 0.33
EBITDA 13.45 15.21 5.63 1.70
NET Worth 17.12 14.73 4.94 2.44
Reserves and Surplus 7.94 5.55 4.84 2.34
Total Borrowing 38.17 15.01 10.49 9.61
Amount in ₹ Crore

Bio Medica Laboratories Company Address

Company Bio Medica Laboratories Ltd.
Address Plot No. 11B-11C,Sector-E, Sanwer RoadIndustrial Area, Industrial Estate (Indore),,
Indore, Madhya Pradesh, 452015
Phone +91 7314102751
Email companysecretary@biomedica.co.in
Website https://www.biomedica.co.in/

Bio Medica Laboratories IPO Registrar

Company Skyline Financial Services Pvt.Ltd.
Phone 02228511022
Email ipo@skylinerta.com
Website https://www.skylinerta.com/ipo.php

Bio Medica Laboratories IPO Lead Manager

  • Narnolia Financial Services Ltd.

Bio Medica Laboratories IPO KPI

KPI Values
ROE 54.41%
ROCE 23.22%
Debt/Equity 2.23
RoNW 54.41%
PAT Margin 30.35%
EBITDA Margin 47.11%

Bio Medica Laboratories IPO - FAQs

Q.What is Bio Medica Laboratories IPO?

Ans.Bio Medica Laboratories IPO is a SME IPO. The IPO is list on NSE SME. The total amount Bio Medica Laboratories aim to raise is 37,72,000 shares (agg. up to ₹52 Cr).


Q.When Bio Medica Laboratories IPO will open?

Ans.Bio Medica Laboratories IPO is to open on 21 May, 2026 for Investors.


Q.What is Bio Medica Laboratories IPO Investors Portion?

Ans.Bio Medica Laboratories investor's portion for QIB is 1.00%, NII is 48.98%, and Retail is 50.01%.


Q.What is Bio Medica Laboratories IPO Size?

Ans.Bio Medica Laboratories IPO size is 37,72,000 shares (agg. up to ₹52 Cr).


Q.What is Bio Medica Laboratories IPO Price Band?

Ans.Bio Medica Laboratories IPO Price Band is ₹132 to ₹139 per share.


Q.What is the Bio Medica Laboratories IPO Allotment Date?

Ans.Bio Medica Laboratories IPO allotment date is 26 May, 2026.


Q.What is the Bio Medica Laboratories IPO Listing Date?

Ans.Bio Medica Laboratories IPO listing date is 29 May, 2026. The IPO is to list on NSE SME.